CIBC Asset Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,350
Closed -$285K 1260
2024
Q3
$285K Buy
+1,350
New +$235K ﹤0.01% 899
2023
Q3
Sell
-799
Closed -$259K 1074
2023
Q2
$259K Buy
+799
New +$228K ﹤0.01% 854
2022
Q2
Sell
-1,142
Closed -$293K 1375
2022
Q1
$293K Hold
1,142
﹤0.01% 1082
2021
Q4
$263K Buy
1,142
+46
+4% +$11.2K ﹤0.01% 1166
2021
Q3
$255K Buy
+1,096
New +$229K ﹤0.01% 1136
2021
Q2
Sell
-997
Closed -$206K 1377
2021
Q1
$206K Buy
+997
New +$212K ﹤0.01% 1234

Other funds holding INSP

CIBC Asset Management's INSP Position: Q4 2024 in Review

CIBC Asset Management sold out of Inspire Medical Systems (INSP) in Q4 2024, closing a stake of 1,350 shares — an estimated $285K sold.

CIBC Asset Management first reported a position in INSP in Q1 2021 and held it in 6 quarters. The position peaked at $293K in Q1 2022. 357 funds tracked by Wall St. Rank hold INSP as of Q4 2024.

  • CIBC Asset Management reported no remaining Inspire Medical Systems position as of Q4 2024 after selling out during the quarter.
  • CIBC Asset Management sold 1,350 Inspire Medical Systems shares in Q4 2024, an estimated $285K.
  • CIBC Asset Management first reported a position in Inspire Medical Systems in Q1 2021 and held it in 6 quarters.
  • CIBC Asset Management's Inspire Medical Systems position peaked at $293K in Q1 2022.
  • 357 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2024.

Based on CIBC Asset Management's 13F filing for Q4 2024, filed 31 Jan 2025.